Previous lung diseases and lung cancer risk: A systematic review and meta-analysis

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Brenner, Darren R ^a,b   McLaughlin, John R ^a,b,c   Hung, Rayjean J ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CANCER CARE ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; EMPHYSEMA; HEALTH SURVEY; HUMAN; LUNG CANCER; LUNG TUBERCULOSIS; PASSIVE SMOKING; PNEUMONIA; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SYSTEMATIC REVIEW; AGED; FEMALE; LUNG DISEASE; LUNG TUMOR; MALE; MEDLINE; META ANALYSIS; REVIEW;

AGED; BRONCHITIS, CHRONIC; EMPHYSEMA; FEMALE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MEDLINE; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79953305328     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017479     Document Type: Article

References (107)

1. Stewart BW, Kleihues P, eds. (2003) World Cancer Report. Lyons, France IARC Press.
2. Peek RM Jr, Mohla S, DuBois RN, (2005) Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting. Cancer Res 65: 8583-8586.
3. Ballaz S, Mulshine JL, (2003) The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 5: 46-62.
4. Rakoff-Nahoum S, Medzhitov R, (2009) Toll-like receptors and cancer. Nat Rev Cancer 9: 57-63.
5. Weitzman SA, Gordon LI, (1990) Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 76: 655-663.
6. Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mark TW, et al. (2000) Ongoing airway inflammation in patients with COPD who Do not currently smoke. Chest 117: 262S.
7. Moldoveanu B, Otmishi P, Jani P, Walker J, Sarmiento X, et al. (2009) Inflammatory mechanisms in the lung. Journal of Inflammation Research pp. 1-11.
8. Azad N, Rojanasakul Y, Vallyathan V, (2008) Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 11: 1-15.
9. American Lung Association (2007) Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. Epidemiology & Statistics Unit Research and Program Services, eds.
10. American Lung Association (2007) Trends in Tuberculosis: Morbidity and Mortality. In: Epidemiology & Statistics Unit Research and Program Service, ed.
11. Rennard SI, (1998) COPD: overview of definitions, epidemiology, and factors influencing its development. Chest 113: 235S-241S.
12. Parmet S, Lynm C, Glass RM, (2003) JAMA patient page. Chronic obstructive pulmonary disease. Jama 290: 2362.
13. Lindberg A, Jonsson AC, Ronmark E, Lundgren R, Larsson LG, et al. (2005) Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration 72: 471-479.
14. Mannino DM, (2002) COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121: 121S-126S.
15. US Surgeon General (1984) The health consequence of smoking: chronic obstructive lung disease. DLIHS Publication No.84-50205. Washington, DC US Department of Health and Human Services.
16. Marsh S, Aldington S, Shirtcliffe P, Weatherall M, Beasley R, (2006) Smoking and COPD: What really are the risks? Eur Respir J 28: 883-884.
17. Alavanja MC, Brownson RC, Boice JD Jr, Hock E, (1992) Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 136: 623-632.
18. Di Dio R, Barberio JC, Pradal MG, Menezes AM, (1994) [Osteocalcin]. Rev Assoc Med Bras 40: 225-227.
19. Stang P, Lydick E, Silberman C, Kempel A, Keating ET, (2000) The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 117: 354S-359S.
20. American Lung Association (2007) Pnuemonia Fact Sheet.
21. Apfalter P, Barousch W, Nehr M, Makristathis A, Willinger B, et al. (2003) Comparison of a new quantitative ompA-based real-Time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays. J Clin Microbiol 41: 592-600.
22. Raviglione MC, Snider DE Jr, Kochi A, (1995) Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. Jama 273: 220-226.
23. Raviglione MC, (2003) The TB epidemic from 1992 to 2002. Tuberculosis (Edinb) 83: 4-14.
24. Steinitz R, (1965) Pulmonary tuberculosis and carcinoma of the lung. A survey from two population-based disease registers. Am Rev Respir Dis 92: 758-766.
25. Campbell AH, (1961) The relationship between cancer and tuberculosis mortality rates. Br J Cancer 15: 10-18.
26. Campbell AH, Lee EJ, (1963) The Relationship between Lung Cancer and Chronic Bronchitis. Br J Dis Chest 57: 113-119.
27. Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, et al. (2010) Lower risk of lung cancer after multiple pneumonia diagnoses. Cancer Epidemiol Biomarkers Prev 19: 716-721.
28. Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, et al. (2009) Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One 4: e7380.
29. Brenner DR, Hung RJ, Tsao MS, Shepherd FA, Johnston MR, et al. (2010) Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors. BMC Cancer 10: 285.
30. Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A, Chen W, et al. (2009) Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. J Thorac Oncol 4: 291-299.
31. Dean G, (1966) Lung cancer and bronchitis in Northern Ireland, 1960-2. Br Med J 1: 1506-1514.
32. Rimington J, (1971) Smoking, chronic bronchitis, and lung cancer. Br Med J 2: 373-375.
33. Davis AL, (1976) Bronchogenic Carcinoma in Chronic Obstructive Pulmonary Disease. JAMA 256: 621-622.
34. Skillrud DM, Offord KP, Miller RD, (1986) Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med 105: 503-507.
35. Skillrud DM, (1986) COPD: causes, treatment, and risk for lung cancer. Compr Ther 12: 13-16.
36. Koyi H, Branden E, Gnarpe J, Gnarpe H, Steen B, (2001) An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. Apmis 109: 572-580.
37. Kocazeybek B, (2003) Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol 52: 721-726.
38. Boffetta P, Ye W, Boman G, Nyren, (2002) Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur Respir J 19: 127-133.
39. Osann KE, Lowery JT, Schell MJ, (2000) Small cell lung cancer in women: risk associated with smoking, prior respiratory disease, and occupation. Lung Cancer 28: 1-10.
40. Neuberger JS, Mahnken JD, Mayo MS, Field RW, (2006) Risk factors for lung cancer in Iowa women: implications for prevention. Cancer Detect Prev 30: 158-167.
41. Boucot KR, Seidman H, Weiss W, (1977) The Philadelphia Pulmonary Neoplasm Research Project. The risk of lung cancer in relation to symptoms and roentgenographic abnormalities. Environ Res 13: 451-469.
42. Tenkanen L, Hakulinen T, Teppo L, (1987) The joint effect of smoking and respiratory symptoms on risk of lung cancer. Int J Epidemiol 16: 509-515.
43. Van den Eeden SK, Friedman GD, (1992) Forced expiratory volume (1 second) and lung cancer incidence and mortality. Epidemiology 3: 253-257.
44. Kuller LH, Ockene J, Meilahn E, Svendsen KH, (1990) Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Epidemiol 132: 265-274.
45. Kishi K, Gurney JW, Schroeder DR, Scanlon PD, Swensen SJ, et al. (2002) The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study. Eur Respir J 19: 1093-1098.
46. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC, (2003) Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 58: 388-393.
47. Purdue MP, Gold L, Jarvholm B, Alavanja MC, Ward MH, et al. (2007) Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 62: 51-56.
48. Tockman MS, Anthonisen NR, Wright EC, Donithan MG, (1987) Airways obstruction and the risk for lung cancer. Ann Intern Med 106: 512-518.
49. Nomura A, Stemmermann GN, Chyou PH, Marcus EB, Buist AS, (1991) Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis 144: 307-311.
50. de Torres JP, Bastarrika G, Wisnivesky JP, Alcaide AB, Campo A, et al. (2007) Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 132: 1932-1938.
51. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, et al. (2008) Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 178: 738-744.
52. Laurila AL, Anttila T, Laara E, Bloigu A, Virtamo J, et al. (1997) Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer 74: 31-34.
53. Jackson LA, Wang SP, Nazar-Stewart V, Grayston JT, Vaughan TL, (2000) Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 9: 1263-1266.
54. Anttila T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, et al. (2003) Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer 107: 681-682.
55. Littman AJ, White E, Jackson LA, Thornquist MD, Gaydos CA, et al. (2004) Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 13: 1624-1630.
56. Hinds MW, Cohen HI, Kolonel LN, (1982) Tuberculosis and lung cancer risk in nonsmoking women. Am Rev Respir Dis 125: 776-778.
57. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA, (1995) A random-effects regression model for meta-analysis. Stat Med 14: 395-411.
58. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315: 629-634.
59. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
60. Cochran W, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
61. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. Bmj 327: 557-560.
62. Samet JM, Humble CG, Pathak DR, (1986) Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis 134: 466-470.
63. Wu AH, Yu MC, Thomas DC, Pike MC, Henderson BE, (1988) Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res 48: 7279-7284.
64. Wu AH, Fontham ET, Reynolds P, Greenberg RS, Buffler P, et al. (1995) Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 141: 1023-1032.
65. Brownson RC, Alavanja MC, (2000) Previous lung disease and lung cancer risk among women (United States). Cancer Causes Control 11: 853-858.
66. Mayne ST, Buenconsejo J, Janerich DT, (1999) Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 149: 13-20.
67. Littman AJ, Thornquist MD, White E, Jackson LA, Goodman GE, et al. (2004) Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control 15: 819-827.
68. Schabath MB, Delclos GL, Martynowicz MM, Greisinger AJ, Lu C, et al. (2005) Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am J Epidemiol 161: 412-422.
69. Schwartz AG, Yang P, Swanson GM, (1996) Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 144: 554-562.
70. Ramanakumar AV, Parent ME, Menzies D, Siemiatycki J, (2006) Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada. Lung Cancer 53: 5-12.
71. Mortensen EM, Copeland LA, Pugh MJ, Fine MJ, Nakashima B, et al. (2010) Diagnosis of pulmonary malignancy after hospitalization for pneumonia. Am J Med 123: 66-71.
72. Yang P, Sun Z, Krowka MJ, Aubry MC, Bamlet WR, et al. (2008) Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med 168: 1097-1103.
73. Gao YT, Blot WJ, Zheng W, Ershow AG, Hsu CW, et al. (1987) Lung cancer among Chinese women. Int J Cancer 40: 604-609.
74. Brenner AV, Wang Z, Kleinerman RA, Wang L, Zhang S, et al. (2001) Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol 30: 118-124.
75. Wang SY, Hu YL, Wu YL, Li X, Chi GB, et al. (1996) A comparative study of the risk factors for lung cancer in Guangdong, China. Lung Cancer 14 (Suppl 1): S99-105.
76. Ger LP, Hsu WL, Chen KT, Chen CJ, (1993) Risk factors of lung cancer by histological category in Taiwan. Anticancer Res 13: 1491-1500.
77. Ko YC, Lee CH, Chen MJ, Huang CC, Chang WY, et al. (1997) Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol 26: 24-31.
78. Lee CH, Ko YC, Cheng LS, Lin YC, Lin HJ, et al. (2001) The heterogeneity in risk factors of lung cancer and the difference of histologic distribution between genders in Taiwan. Cancer Causes Control 12: 289-300.
79. Wang XR, Yu IT, Chiu YL, Qiu H, Fu Z, et al. (2009) Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women. Cancer Causes Control 20: 757-763.
80. Galeone C, Pelucchi C, La Vecchia C, Negri E, Bosetti C, et al. (2008) Indoor air pollution from solid fuel use, chronic lung diseases and lung cancer in Harbin, Northeast China. Eur J Cancer Prev 17: 473-478.
81. Liu ZY, He XZ, Chapman RS, (1991) Smoking and other risk factors for lung cancer in Xuanwei, China. Int J Epidemiol 20: 26-31.
82. Shen XB, Wang GX, Huang YZ, Xiang LS, Wang XH, (1996) Analysis and estimates of attributable risk factors for lung cancer in Nanjing, China. Lung Cancer 14 (Suppl 1): S107-112.
83. Liang H, Guan P, Yin Z, Li X, He Q, et al. (2009) Risk of lung cancer following nonmalignant respiratory conditions among nonsmoking women living in Shenyang, Northeast China. J Womens Health (Larchmt) 18: 1989-1995.
84. Wu-Williams AH, Dai XD, Blot W, Xu ZY, Sun XW, et al. (1990) Lung cancer among women in north-east China. Br J Cancer 62: 982-987.
85. Kreuzer M, Heinrich J, Kreienbrock L, Rosario AS, Gerken M, et al. (2002) Risk factors for lung cancer among nonsmoking women. Int J Cancer 100: 706-713.
86. Kreuzer M, Gerken M, Kreienbrock L, Wellmann J, Wichmann HE, (2001) Lung cancer in lifetime nonsmoking men- results of a case-control study in Germany. Br J Cancer 84: 134-140.
87. Vestbo J, Knudsen KM, Rasmussen FV, (1991) Are respiratory symptoms and chronic airflow limitation really associated with an increased risk of respiratory cancer? Int J Epidemiol 20: 375-378.
88. Sasco AJ, Merrill RM, Dari I, Benhaim-Luzon V, Carriot F, et al. (2002) A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control 13: 609-616.
89. Gorlova OY, Zhang Y, Schabath MB, Lei L, Zhang Q, et al. (2006) Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer 118: 1798-1804.
90. Zatloukal P, Kubik A, Pauk N, Tomasek L, Petruzelka L, (2003) Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history. Lung Cancer 41: 283-293.
91. Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, et al. (2008) The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 98: 270-276.
92. Zheng W, Blot WJ, Liao ML, Wang ZX, Levin LI, et al. (1987) Lung cancer and prior tuberculosis infection in Shanghai. Br J Cancer 56: 501-504.
93. Cocco P, Rice CH, Chen JQ, McCawley M, McLaughlin JK, et al. (2000) Non-malignant respiratory diseases and lung cancer among Chinese workers exposed to silica. J Occup Environ Med 42: 639-644.
94. Engels EA, Shen M, Chapman RS, Pfeiffer RM, Yu YY, et al. (2009) Tuberculosis and subsequent risk of lung cancer in Xuanwei, China. Int J Cancer 124: 1183-1187.
95. Chan-Yeung M, Koo LC, Ho JC, Tsang KW, Chau WS, et al. (2003) Risk factors associated with lung cancer in Hong Kong. Lung Cancer 40: 131-140.
96. Wang TJ, Zhou BS, Shi JP, (1996) Lung cancer in nonsmoking Chinese women: a case-control study. Lung Cancer 14 (Suppl 1): S93-98.
97. Engels EA, (2008) Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther 8: 605-615.
98. Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD, (2005) Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 60: 570-575.
99. (2004) The effect of tuberculosis control in China. Lancet 364: 417-422.
100. Chapman KR, Tashkin DP, Pye DJ, (2001) Gender bias in the diagnosis of COPD. Chest 119: 1691-1695.
101. Stayner L, Bena J, Sasco AJ, Smith R, Steenland K, et al. (2007) Lung cancer risk and workplace exposure to environmental tobacco smoke. Am J Public Health 97: 545-551.
102. Reardon JZ, (2007) Environmental tobacco smoke: respiratory and other health effects. Clin Chest Med 28: 559-573, vi.
103. Moulin JJ, (1997) A meta-analysis of epidemiologic studies of lung cancer in welders. Scand J Work Environ Health 23: 104-113.
104. Defrances C, Hall MJ, (2007) 2005 Hospital Discharge Survey. Advance Data From Vital and Health Statistics 385.
105. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-867.
106. Fitzpatrick FA, (2001) Inflammation, carcinogenesis and cancer. Int Immunopharmacol 1: 1651-1667.
107. Lin WW, Karin M, (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117: 1175-1183.